Biotechnology Fund Correlations
| RYOIX Fund | USD 85.77 0.18 0.21% |
The current 90-days correlation between Biotechnology Fund and Deutsche Health And is 0.04 (i.e., Significant diversification). The correlation of Biotechnology Fund is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Biotechnology Fund Correlation With Market
Good diversification
The correlation between Biotechnology Fund Investor and DJI is -0.08 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Fund Investor and DJI in the same portfolio, assuming nothing else is changed.
Biotechnology |
Moving together with Biotechnology Mutual Fund
| 1.0 | RYBOX | Biotechnology Fund Class | PairCorr |
| 0.64 | RYAEX | Europe 125x Strategy | PairCorr |
| 0.61 | RYAGX | Inverse Mid Cap | PairCorr |
| 0.62 | RYATX | Nasdaq 100 Fund | PairCorr |
| 0.67 | RYDHX | Dow Jones Industrial | PairCorr |
| 0.65 | RYDKX | Dow Jones Industrial | PairCorr |
| 0.98 | RYCFX | Biotechnology Fund Class | PairCorr |
Moving against Biotechnology Mutual Fund
| 0.66 | RYAWX | Sp 500 Pure | PairCorr |
| 0.59 | RYACX | Inverse Nasdaq 100 | PairCorr |
| 0.59 | RYAIX | Inverse Nasdaq 100 Potential Growth | PairCorr |
| 0.58 | RYALX | Inverse Nasdaq 100 | PairCorr |
| 0.58 | RYAPX | Inverse Nasdaq 100 | PairCorr |
| 0.53 | RYARX | Inverse Sp 500 | PairCorr |
| 0.47 | RYAVX | Sp Midcap 400 | PairCorr |
| 0.43 | RYDCX | Mid Cap 15x | PairCorr |
| 0.41 | RYAHX | Mid Cap 15x | PairCorr |
| 0.76 | RYFNX | Financial Services | PairCorr |
| 0.74 | RYFIX | Financial Services | PairCorr |
| 0.71 | RYCPX | Consumer Products | PairCorr |
| 0.69 | RYCAX | Consumer Products | PairCorr |
| 0.68 | RYCIX | Consumer Products | PairCorr |
| 0.65 | RYCDX | Rydex Inverse Nasdaq | PairCorr |
| 0.65 | RYCZX | Inverse Dow 2x | PairCorr |
| 0.63 | RYCWX | Inverse Dow 2x | PairCorr |
| 0.58 | RYCBX | Inverse Sp 500 | PairCorr |
Related Correlations Analysis
| 0.87 | 0.99 | 0.92 | 0.93 | 0.98 | SCHLX | ||
| 0.87 | 0.88 | 0.98 | 0.95 | 0.88 | ETAHX | ||
| 0.99 | 0.88 | 0.92 | 0.92 | 0.97 | LOGSX | ||
| 0.92 | 0.98 | 0.92 | 0.98 | 0.93 | LHCCX | ||
| 0.93 | 0.95 | 0.92 | 0.98 | 0.92 | RAGHX | ||
| 0.98 | 0.88 | 0.97 | 0.93 | 0.92 | FHCCX | ||
Risk-Adjusted Indicators
There is a big difference between Biotechnology Mutual Fund performing well and Biotechnology Fund Mutual Fund doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Biotechnology Fund's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SCHLX | 0.63 | 0.11 | 0.11 | 0.25 | 0.50 | 2.14 | 4.75 | |||
| ETAHX | 1.06 | 0.39 | 0.25 | (2.38) | 0.72 | 3.21 | 5.64 | |||
| LOGSX | 0.62 | 0.14 | 0.14 | 0.33 | 0.49 | 1.82 | 3.90 | |||
| LHCCX | 0.75 | 0.22 | 0.15 | (2.91) | 0.63 | 1.80 | 4.51 | |||
| RAGHX | 0.72 | 0.18 | 0.12 | (5.38) | 0.54 | 2.08 | 4.55 | |||
| FHCCX | 0.75 | 0.13 | 0.11 | 0.26 | 0.72 | 1.67 | 5.11 |